$Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?$

Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?

To evaluate the efficacy of etoricoxib in patients with axial ankylosing spondyloarthritis (AS) refractory to traditional NSAIDs. This was an open label, multicentric, randomised, prospective (4 weeks with and open extension to 6 months), non-controlled study. Consecutive patients with axial AS refr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental rheumatology 2016-01, Vol.34 (1), p.94-99
Hauptverfasser:	Gratacós, Jordi, Moreno Martínez-Losa, Mireia, Font, Pilar, Montilla, Carlos, Fernández-Espartero, Cruz, Linares, Luis Francisco, Brito, Elia, Oliva, Juan Carlos, Collantes-Estevez, Eduardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Cyclooxygenase 2 Inhibitors - adverse effects Cyclooxygenase 2 Inhibitors - therapeutic use Drug Resistance Drug Substitution Female Humans Male Middle Aged Pyridines - adverse effects Pyridines - therapeutic use Remission Induction Spain Spondylitis, Ankylosing - diagnosis Spondylitis, Ankylosing - drug therapy Sulfones - adverse effects Sulfones - therapeutic use Time Factors Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!